Drug Detail

Information about Telaglenastat + Talazoparib

Generic Name	Telaglenastat + Talazoparib
IND	CB-139 + BMN-673
Brand Name (US)
Manufacturer	Calithera & Pfizer
Drug Type
Delivery	Oral
Approval Status
Indications
Overall Strategy	Cell metabolism and DNA damage repair
Strategy	Inhibit Glycolysis and inhibit DNA DSB repair
Drug Category	SDH-directed

Links
Trials of this drug
	Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

Trial results